Risk factors for end-stage renal disease in a community-based population: 26-year follow-up of 25 821 men and women in eastern Finland

Journal of Internal Medicine

Volumn 267, Issue 6, 2010, Pages 612-620

  Kastarinen, M ^a   Juutilainen, A ^a,b   Kastarinen, H ^a   Salomaa, V ^c   Karhapaa P ^a   Tuomilehto, J ^c,d   Gronhagen Riska C ^e   Jousilahti, P ^c   Finne, P ^e,f  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d SOUTH OSTROBOTHNIA CENTRAL HOSPITAL   (Finland)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^f UNIVERSITY OF TAMPERE   (Finland)

Author keywords

Cohort studies; Kidney failure; Risk factors

Indexed keywords

CHOLESTEROL;

ADULT; ARTICLE; BODY MASS; CIGARETTE SMOKING; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEATH; DIABETES MELLITUS; DISEASE REGISTRY; FEMALE; FINLAND; FOLLOW UP; HEALTH CARE PLANNING; HEMODIALYSIS; HUMAN; HYPERTENSION; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OBESITY; PERITONEAL DIALYSIS; PHYSICAL ACTIVITY; PREDICTION; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE;

ADULT; COHORT STUDIES; FEMALE; FINLAND; FOLLOW-UP STUDIES; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK FACTORS;

EID: 77951903189     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2009.02197.x     Document Type: Article

References (48)

1. El Nahas AM, Bello AK. Chronic kidney disease: the global challenge. Lancet 2005 365 : 331 340. (Pubitemid 40139112)
2. United States Renal Data System. Annual data report: incidence and prevalence of ESRD. http://www.usrds.org. Accessed June 18, 2009.
3. The Renal Association, UK Renal Registry. The Ninth annual report. http://www.renalreg.com. Accessed June 18, 2009.
4. Finnish Registry for Kidney Diseases. Finnish Registry for Kidney Diseases Report 2007.
5. Coresh J, Selvin E, Stevens LA et al. Prevalence of chronic kidney disease in the United States. JAMA 2007 298 : 2038 2047. (Pubitemid 350074801)
6. Zhang QL, Rothenbacher D. Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Public Health 2008 8 : 117. (Pubitemid 351678123)
7. Klag MJ, Whelton PK, Randall BL et al. Blood pressure and end-stage renal disease in men. N Engl J Med 1996 334 : 13 8.
8. Tozawa M, Iseki K, Iseki C, Kinjo K, Ikemiya Y, Takishita S. Blood pressure predicts risk of developing end-stage renal disease in men and women. Hypertension 2003 41 : 1341 1345. (Pubitemid 36706087)
9. Hsu C, McCulloch CE, Darbinian J, Go AS, Iribarren C. Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease. Arch Intern Med 2005 165 : 923 928. (Pubitemid 40563240)
10. Reynolds K, Gu D, Muntner P et al. A population-based, prospective study of blood pressure and risk for end-stage renal disease in China. J Am Soc Nephrol 2007 18 : 1928 1935. (Pubitemid 46870330)
11. Iseki K, Ikemiya Y, Kinjo K, Inoue T, Iseki C, Takishita S. Body mass index and the risk for development of end-stage renal disease in a screened cohort. Kidney Int 2004 65 : 1870 1876. (Pubitemid 38591038)
12. Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS. Body mass index and risk for end-stage renal disease. Ann Intern Med 2006 144 : 21 8. (Pubitemid 46780716)
13. Reynolds K, Gu D, Muntner P et al. Body mass index and risk of ESRD in China. Am J Kidney Dis 2007 50 : 754 764. (Pubitemid 47588564)
14. Iseki K, Ikemiya Y, Inoue T, Iseki C, Kinjo K, Takishita S. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort. Am J Kidney Dis 2004 44 : 642 650. (Pubitemid 39237608)
15. Iseki K, Ikemiya Y, Iseki C, Takishita S. Proteinuria and the risk for developing end-stage renal disease. Kidney Int 2003 63 : 1468 1474. (Pubitemid 36350012)
16. Iseki K, Kinjo K, Iseki C, Takishita S. relationship between predicted creatinine clearance and proteinuria and the risk of developing ESRD in Okinawa, Japan. Am J Kidney Dis 2004 44 : 806 814. (Pubitemid 39445912)
17. Ishani A, Grandits GA, Grimm RH et al. Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial. J Am Soc Nephrol 2006 17 : 1444 1452. (Pubitemid 43673426)
18. Iseki K, Ikemiya Y, Iseki C, Takishita S. Haemotocrit and the risk of developing end-stage renal disease. Nephrol Dial Transplant 2003 18 : 899 905. (Pubitemid 36592530)
19. Hsu CY, Iribarren C, McCulloch CE, Darbinian J, Go AS. Risk factors for end-stage renal disease: 25-year follow-up. Arch Intern Med 2009 169 : 342 350.
20. Hallan S, Ritz E, Lydersen S, Romundstad S, Kvenelid K, Orth S. Combining GFR and albuminuria to classify CKD improves prediction of ESRD. J Am Soc Nephrol 2009 20 : 1069 1077.
21. Vikse BE, Irgens LM, Leivenstad T, Hallan S, Iversen BM. Low birth weight increases risk for end-stage renal disease. J Am Soc Nephrol 2008 19 : 151 157.
22. Vikse BE, Irgens LM, Leivestad T, Skjaerven R, Iversen BM. Preeclampsia and the risk for end-stage renal disease. N Engl J Med 2008 359 : 800 809.
23. Puska P, Nissinen A, Tuomilehto J et al. The community-based strategy to prevent coronary heart disease: conclusions from the ten years of the North Karelia Project. Annu Rev Public Healh 1985 6 : 147 193.
24. WHO MONICA Project Principal Investigators. The World Health Organization Monica Project (Monitoring trends and determinants in cardiovascular disease): a major international collaboration. J Clin Epidemiol 1988 41 : 105 114.
25. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data.
26. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999 94 : 496 509.
27. Molenaar EA, Ameijden EJ, Grobbee DE, Numans ME. Comparison of routine care self-reported and biometrical data on hypertension and diabetes: results of the Utrecht Health Project. Eur J Public Health 2007 17 : 199 205.
28. Tuomilehto J, Lindström J, Eriksson JG et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001 344 : 1343 1350. (Pubitemid 32378388)
29. Diabetes Prevention Research Group. Reduction in incidence of type 2 diabetes with life-style intervention or metformin. N Engl J Med 2002 346 : 393 403. (Pubitemid 34437694)
30. Fox CS, Larson MG, Leip EP, Culleton BC, Wilson PWF, Levy D. Predictors of new-onset kidney disease in a community-based population. JAMA 2004 291 : 844 850. (Pubitemid 38543772)
31. Domrongkitchaiporn S, Sritara P, Kitiyakara C et al. Risk factors for development of decreased kidney function in a southeast Asian population: a 12-year cohort study. J Am Soc Nephrol 2005 16 : 791 799. (Pubitemid 41725116)
32. Lastra G, Manrique C, Sowers JR. Obesity, cardiometabolic syndrome, and chronic kidney disease: the weight of the evidence. Adv Chronic Kidney Dis 2006 13 : 365 373. (Pubitemid 44512240)
33. Tomaszewski M, Charchar FJ, Maric C et al. Glomerular hyperfiltration: a new marker of metabolic risk. Kidney Int 2007 71 : 816 821. (Pubitemid 46624026)
34. Kambham N, Markowitz GS, Valeri AM. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int 2001 59 : 1498 1509. (Pubitemid 32281241)
35. Bello AK, De Zeeuw D, El Nahas M et al. Impact of weight change on albuminuria in the general population. Nephrol Dial Transplant 2007 22 : 1619 1627. (Pubitemid 47073760)
36. James WPT. The epidemiology of obesity: the size of the problem. J Intern Med 2008 263 : 336 352.
37. El Nahas AM. Glomerusclerosis: a form of atherosclerosis. Nephrology 1988 2 : 1206 1220.
38. El Nahas AM. Plasticity of kidney cells: role in kidney remodelling and scarring. Kidney Int 2003 64 : 1553 1563. (Pubitemid 37323683)
39. Pavenstadt H, Kriz W, Kretzler M. Cell biology of the glomerular podocyte. Physiol Rev 2003 83 : 253 307. (Pubitemid 36459882)
40. Kastarinen MJ, Antikainen RL, Peltonen M et al. Prevalence, awareness and treatment of hypertension in Finland during 1982-2007. J Hypertens 2009 27 : 1552 1559.
41. Hajjar I, Kotchen JM, Kotchen TA. Hypertension: trends in prevalence, incidence, and control. Annu Rev Public Health 2006 27 : 465 490.
42. Cutler JA, Sorlie PD, Wolz M, Thom T, Fields LE, Roccella EJ. Trends in hypertension prevalence, awareness, treatment and control rates in United States adults between 1988-1994 and 1999-2004. Hypertension 2008 52 : 818 827.
43. Pinto-Sietsma SJ, Mulder J, Janssen WM, Hillege HL, de Zeeuw D, de Jong PE. Smoking is related to albuminuria and abnormal renal function in nondiabetic persons. Ann Intern Med 2000 133 : 585 591.
44. Haroun MK, Jaar BG, Hoffman SC, Comstock GW, Klag MJ, Coresh J. Risk factors for chronic kidney disease: a prospective study of 23,534 men and women in Washington County, Maryland. J Am Soc Nephrol 2003 14 : 2934 2941. (Pubitemid 37305656)
45. Yamagata K, Ishida K, Sairenchi T et al. Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. Kidney Int 2007 71 : 159 166. (Pubitemid 46094690)
46. Orth SR, Stöckmann A, Conradt C, Ritz E. Smoking as a risk factor for end-stage renal failure in men with primary renal disease. Kidney Int 1998 54 : 926 931. (Pubitemid 28397411)
47. Orth SR, Hallan SI. Smoking: a risk factor for progression of chronic kidney disease and for cardiovascular morbidity and mortality in renal patients - absence of evidence or evidence of absence? Clin J Am Soc Nephrol 2008 3 : 226 236.
48. Fried LF. Effects of HNG-CoA reductase inhibitors (statins) on progression of kidney disease. Kidney Int 2008 74 : 571 576.